The Future of Prostate Cancer Imaging
Prostate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.
Prostate Cancer Imaging: the VISION Trial
Neal Shore, MD, FACS, reviews the VISION clinical trial in prostate cancer imaging.
Patient Profile 7: Gleason 7 Prostate Cancer
A look at the patient profile of a 62-year-old man presenting with reduced urinary flow and hematuria.
Patient Profile 6: Robotic Radical Prostatectomy for Adenocarcinoma
Dr Steven Finkelstein explains a clinical example of a 65-year-old patient with a history of robotic radical prostatectomy for Gleason 9 adenocarcinoma.
Patient Profile 5: IMRT for Adenocarcinoma
Dr Lawrence Saperstein describes the patient profile of a 78-year-old man with a history of intensity-modulated radiation therapy for adenocarcinoma.
Prostate Cancer Imaging: the CONDOR Trial
Key opinion leaders review the CONDOR clinical trial studying PSMA PET scans for prostate cancer imaging.
Patient Profile 4: Recurrent Prostate Cancer
Michael Gorin, MD, presents a clinical example of a 60-year-old patient with recurrent prostate cancer.
Bone Scans for Prostate Cancer Imaging
A panel of experts review whether bone scans still have a place in prostate cancer imaging.
Patient Profile 3: High-Risk Prostate Cancer
Steven Finkelstein, MD, DABR, FACRO, presents a high-risk prostate cancer patient profile for a 74-year-old man with a history of chronic prostatitis.
Patient Profile 2: High-Risk Prostate Cancer
Lawrence Saperstein, MD, reviews the patient profile of a 65-year-old man with high-risk prostate cancer.
The Role for PSMA PET Imaging in Prostate Cancer Monitoring
A look at how PSMA PET imaging fits into the monitoring of a patient with prostate cancer.
Discussing Treatments with Patients Based on Prostate Cancer Imaging
A radiation oncologist explains how to discuss the interpretation of prostate cancer imaging with patients in deciding on a treatment plan.
Visual Analysis vs SUV for Prostate Cancer Imaging
Dr Lawrence Saperstein describes the importance of coronal images and visual analysis in making a thoughtful treatment plan for prostate cancer.
Key Messages from the OSPREY Trial
Authors from the OSPREY clinical trial highlight the key take-home messages from the trial outcomes.
Prostate Cancer Imaging: the OSPREY Trial
Key opinion leaders review the OSPREY clinical trial studying PSMA PET scans for prostate cancer imaging.
Patient Profile 1: High-Risk Localized Prostate Cancer
Doctors present the patient profile of a 66-year-old man with high-risk localized prostate cancer.
The Learning Curve of PSMA PET Scans
Michael Gorin, MD, describes his experiences with prostate cancer imaging both in academia and community-based practices.
The Multidisciplinary Approach to Prostate Cancer Management
An explanation of the importance of clinical providers following a multidisciplinary approach for prostate cancer management.
PSMA PET Clinical Trials
Experts review ongoing clinical trials in PSMA PET technology.
PSMA PET Scans for Prostate Cancer Imaging
The panel explains the science behind PSMA PET scans and reviews the different positron-emitters used in the scans.
Rapid Advances in Prostate Cancer Imaging
A background on the available options and recent advances in prostate cancer imaging.
2 Clarke Drive Cranbury, NJ 08512